Trans-Hit Biomarkers - Ownership and Business Overview

Life ScienceCompany

Trans-Hit Biomarkers Ownership

Who owns Trans-Hit Biomarkers?

Trans-Hit Biomarkers is owned by Azenta. It was acquired on December 3, 2020.

Trans-Hit Biomarkers Business Overview

Where is Trans-Hit Biomarkers headquartered?

Trans-Hit Biomarkers is headquartered in Laval, Quebec.

What sector is Trans-Hit Biomarkers in?

Trans-Hit Biomarkers is a life science company.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 284 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 261 by strategics.

Trans-Hit Biomarkers, Inc.

3090 le Carrefour Boulevard, Suite 750,
Laval, Quebec H2T 2J7
Canada,
(514) 739-0670
www.trans-hit.com

Trans-Hit Biomarkers, Inc. is a worldwide biospecimen procurement service provider that has an extensive collection capability for biospecimens and clinical samples through a worldwide partner network of clinical sites and biobanks. THB is enabled by a team with an extensive background in biomedical research that advises biopharma and diagnostic clients on the best solutions to design, organize and conduct sample collections in various fields including oncology and infectious diseases. Trans-Hit Biomarkers is based in Laval, Quebec.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Trans-Hit Biomarkers

Quebec Companies , Life Science Companies , Canada Companies , Quebec Life Science Companies , Quebec Life Science with Acquisitions , Quebec Life Science with Divestitures

Related Lists for Quebec Companies

Largest Quebec Companies , Acquisitive Quebec Companies , Recently Acquired Quebec Companies , Recently Sold Quebec Companies , Private Quebec Companies , Public Quebec Companies , Acquired Quebec Companies , PE Backed Quebec Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Canada Companies

Largest Canada Companies , Acquisitive Canada Companies , Recently Acquired Canada Companies , Recently Sold Canada Companies , Private Canada Companies , Public Canada Companies , Acquired Canada Companies , PE Backed Canada Companies
Mergr

Product

Company

Legal